Baumer

Baumer FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Baumer (BALM4.SA) as of Nov 10, 2026 is 72.72 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 202.18 % — a change of -64.03% (lower).

FCF Conversion

72.72 %

YoY

-64.03%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Baumer is 2024 72.72 % . FCF Conversion Rate (FCF/EBITDA) of Baumer was 2023 202.18 % . It decreases by -64.03% lower compared to the previous year.

The Baumer FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
606.22 BRL
Jan 1, 2018
-207.95 BRL
Jan 1, 2019
112.96 BRL
Jan 1, 2020
121.96 BRL
Jan 1, 2021
80.31 BRL
Jan 1, 2022
-51.35 BRL
Jan 1, 2023
202.18 BRL
Jan 1, 2024
72.72 BRL
The Baumer FCF Conversion history
YEARFCF ConversionYoY
72.72 %-64.03%
202.18 %-493.71%
-51.35 %-163.94%
80.31 %-34.15%
121.96 %+7.98%
112.96 %-154.32%
-207.95 %-134.30%
606.22 %-1,116.32%
-59.65 %-669.49%
10.47 %+91.75%
5.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

FCF Conversion Rate (FCF/EBITDA) of Baumer is 72.72 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Baumer changed from 202.18 % to 72.72 %, representing a -64.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Baumer since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Baumer with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Baumer

All Key Metrics — Baumer